Avita Medical, Inc.Avita Medical, Inc.Avita Medical, Inc.

Avita Medical, Inc.

No trades
See on Supercharts
Market capitalization
‪230.85 M‬USD
−1.40USD
‪−35.38 M‬USD
‪50.14 M‬USD
‪23.76 M‬
Beta (1Y)
3.78

About Avita Medical, Inc.

CEO
James M. Corbett
Headquarters
Valencia
Employees (FY)
207
Founded
2020
FIGI
BBG00TD18T43
AVITA Medical, Inc., through its subsidiaries, engages in the development and commercialization of a technology platform that enables point-of-care autologous skin restoration for multiple unmet needs. Its product, RECELL system, is a device that enables healthcare professionals to produce a suspension of spray-on skin cells using a small sample of the patient's own skin for the treatment of acute thermal burns. The company was founded in December 1992 and is headquartered in Valencia, CA.
Performance
Revenue to profit conversion
Debt level and coverage
Earnings
Next:
‪0.00‬
Summarizing what the indicators are suggesting.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
An aggregate view of professional's ratings.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Trade directly on the supercharts through our supported, fully-verified and user-reviewed brokers.

Frequently Asked Questions

The current price of RCEL is 8.57 USD — it has decreased by 4.57% in the past 24 hours.
Depending on the exchange, the stock ticker may vary. For instance, on NASDAQ exchange Avita Medical, Inc. stocks are traded under the ticker RCEL.
Avita Medical, Inc. is going to release the next earnings report on May 13, 2024. Keep track of upcoming events with our Earnings Calendar.
RCEL stock is 8.68% volatile and has beta coefficient of 3.78. Check out the list of the most volatile stocks — is Avita Medical, Inc. there?
RCEL earnings for the last quarter are −0.34 USD per share, whereas the estimation was −0.44 USD resulting in a 21.90% surprise. The estimated earnings for the next quarter are −0.38 USD per share. See more details about Avita Medical, Inc. earnings.
Avita Medical, Inc. revenue for the last quarter amounts to ‪13.65 M‬ USD despite the estimated figure of ‪13.40 M‬ USD. In the next quarter revenue is expected to reach ‪14.20 M‬ USD.
Yes, you can track Avita Medical, Inc. financials in yearly and quarterly reports right on TradingView.
RCEL stock has fallen by 12.64% compared to the previous week, the month change is a 45.10% fall, over the last year Avita Medical, Inc. has showed a 39.90% decrease.
RCEL net income for the last quarter is ‪−7.07 M‬ USD, while the quarter before that showed ‪−8.71 M‬ USD of net income which accounts for 18.90% change. Track more Avita Medical, Inc. financial stats to get the full picture.
Today Avita Medical, Inc. has the market capitalization of ‪223.09 M‬, it has decreased by 11.86% over the last week.
No, RCEL doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
Like other stocks, RCEL shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade Avita Medical, Inc. stock right from TradingView charts — choose your broker and connect to your account.
RCEL reached its all-time high on Feb 19, 2020 with the price of 55.35 USD, and its all-time low was 3.75 USD and was reached on Nov 20, 2017.
See other stocks reaching their highest and lowest prices.
As of Apr 25, 2024, the company has 207.00 employees. See our rating of the largest employees — is Avita Medical, Inc. on this list?
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So Avita Medical, Inc. technincal analysis shows the sell today, and its 1 week rating is sell. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating Avita Medical, Inc. stock shows the strong sell signal. See more of Avita Medical, Inc. technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.
We've gathered analysts' opinions on Avita Medical, Inc. future price: according to them, RCEL price has a max estimate of 40.00 USD and a min estimate of 9.34 USD. Read a more detailed Avita Medical, Inc. forecast: see what analysts think of Avita Medical, Inc. and suggest that you do with its stocks.
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. Avita Medical, Inc. EBITDA is ‪−121.55 M‬ USD, and current EBITDA margin is −241.99%. See more stats in Avita Medical, Inc. financial statements.